Molecular hybridization based on (-)-epigallocatechin gallate as a new class of antiglycation agents

Biosci Biotechnol Biochem. 2021 Apr 24;85(5):1069-1076. doi: 10.1093/bbb/zbab020.

Abstract

(-)-Epigallocatechin gallate (EGCG) and olivetol hybrid molecules 1-4 were conveniently synthesized using dielectric barrier discharge plasma irradiation. The structures of these unprecedented hybrid molecules were determined by interpretation of spectroscopic data. The unusual hybrid 1 showed improved antiglycation potency toward the advanced formation of glycation end products than the original EGCG and olivetol. The novel hybrid 1 is an interesting new class of antiglycation candidate that requires further investigation.

Keywords: (−)-epigallocatechin gallate; antiglycation; dielectric barrier discharge plasma; hybrid molecules; olivetol.

MeSH terms

  • Animals
  • Catechin / analogs & derivatives*
  • Catechin / chemistry
  • Catechin / pharmacology
  • Cattle
  • Chemistry Techniques, Synthetic
  • Fructose / chemistry
  • Glucose / chemistry
  • Glycation End Products, Advanced / antagonists & inhibitors*
  • Glycation End Products, Advanced / chemistry
  • Glycosylation / drug effects
  • Magnetic Resonance Spectroscopy
  • Plasma Gases / chemistry
  • Resorcinols / chemistry*
  • Resorcinols / pharmacology
  • Serum Albumin, Bovine / chemistry*
  • Solutions

Substances

  • Glycation End Products, Advanced
  • Plasma Gases
  • Resorcinols
  • Solutions
  • Serum Albumin, Bovine
  • Fructose
  • olivetol
  • Catechin
  • epigallocatechin gallate
  • Glucose